United Therapeutics Corporation
Martine A Rothblatt (Chairperson & CEO) sells UTHR shares
AI-generated summary
Chairperson & CEO, Director Martine A Rothblatt exercised 9,500 options for 9,500 shares at an average price of $117.76 valued at $1,118,720, and sold 9,500 shares at an average price of $585.49 valued at $5,562,190. Following these transactions, the insider held 324,443 shares indirectly by Trust. These transactions were made under a Rule 10b5-1 trading plan adopted on November 7, 2025.
Key facts
- Insider
- Martine A Rothblatt · Chairperson & CEO, Director
Rule 10b5-1 plan · adopted Nov 7, 2025
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 28, 2026 | M · exercise or conversion of a derivativeFootnotes F1, F2 | +9,500 | $117.76 | $1,118,720.00 | 333,943 | Indirect (by Trust) |
| Oct 28, 2026 | S · open-market saleFootnotes F1, F3, F2 | −821 | $583.50 | $479,054.90 | 333,122 | Indirect (by Trust) |
| Oct 28, 2026 | S · open-market saleFootnotes F1, F4, F2 | −2,625 | $584.43 | $1,534,132.43 | 330,497 | Indirect (by Trust) |
| Oct 28, 2026 | S · open-market saleFootnotes F1, F5, F2 | −1,902 | $585.36 | $1,113,351.87 | 328,595 | Indirect (by Trust) |
| Oct 28, 2026 | S · open-market saleFootnotes F1, F6, F2 | −3,086 | $586.37 | $1,809,535.97 | 325,509 | Indirect (by Trust) |
| Oct 28, 2026 | S · open-market saleFootnotes F1, F7, F2 | −986 | $587.27 | $579,043.59 | 324,523 | Indirect (by Trust) |
| Oct 28, 2026 | S · open-market saleFootnotes F1, F8, F2 | −80 | $588.39 | $47,071.30 | 324,443 | Indirect (by Trust) |
| Oct 28, 2026 | M · exercise or conversion of a derivativeStock OptionFootnotes F1, F12, F13 | −9,500 | $0.00 | $0.00 | 138,410 | Indirect (by Trust) |
Footnotes
- F1 This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10 Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F11 Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F12 These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.
- F13 Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F2 Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F3 This transaction was executed in multiple trades at prices ranging from $582.91 to $583.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4 This transaction was executed in multiple trades at prices ranging from $583.92 to $584.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5 This transaction was executed in multiple trades at prices ranging from $584.92 to $585.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6 This transaction was executed in multiple trades at prices ranging from $585.95 to $586.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7 This transaction was executed in multiple trades at prices ranging from $586.96 to $587.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8 This transaction was executed in multiple trades at prices ranging from $588.00 to $588.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9 Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
More UTHR filings
- 4
Filed Oct 30, 2026
- 4
Filed Oct 28, 2026
- 4
Filed Oct 27, 2026
- 4
Filed Oct 26, 2026
- 4
Filed Oct 23, 2026
- 4
Filed Oct 22, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.